These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 10586493)

  • 1. [Azimilide: Search for an effective and well-tolerated anti-arrhythmia agent].
    Z Kardiol; 1999 Oct; 88(10 Suppl):1-2. PubMed ID: 10586493
    [No Abstract]   [Full Text] [Related]  

  • 2. Azimilide. NE 10064, Stedicor.
    Drugs R D; 1999 Apr; 1(4):297-300. PubMed ID: 10566048
    [No Abstract]   [Full Text] [Related]  

  • 3. Azimilide dihydrochloride: a unique class III antiarrhythmic agent.
    Tran HT
    Heart Dis; 1999; 1(2):114-6. PubMed ID: 11720612
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Azimilide.
    Clemett D; Markham A
    Drugs; 2000 Feb; 59(2):271-7; discussion 278-9. PubMed ID: 10730550
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Newer antiarrhythmic drugs.
    Gupta AK; Maheshwari A; Thakur RK; Lokhandwala YY
    Indian Heart J; 2001; 53(3):354-60. PubMed ID: 11516042
    [No Abstract]   [Full Text] [Related]  

  • 6. Azimilide dihydrochloride, a novel antiarrhythmic agent.
    Karam R; Marcello S; Brooks RR; Corey AE; Moore A
    Am J Cardiol; 1998 Mar; 81(6A):40D-46D. PubMed ID: 9537222
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Azimilide dihydrochloride: a new class III anti-arrhythmic agent.
    Abrol R; Page RL
    Expert Opin Investig Drugs; 2000 Nov; 9(11):2705-15. PubMed ID: 11060832
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The azimilide post-infarct survival evaluation (ALIVE) trial.
    Camm AJ; Karam R; Pratt CM
    Am J Cardiol; 1998 Mar; 81(6A):35D-39D. PubMed ID: 9537221
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Progress in the clinical use of anti-arrhythmic drugs (I)].
    Li WZ
    Zhonghua Er Ke Za Zhi; 2003 Oct; 41(10):735-7. PubMed ID: 14731351
    [No Abstract]   [Full Text] [Related]  

  • 10. Suppression of inducible ventricular arrhythmias by intravenous azimilide in dogs with previous myocardial infarction.
    Drexler AP; Micklas JM; Brooks RR
    J Cardiovasc Pharmacol; 1996 Dec; 28(6):848-55. PubMed ID: 8961084
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy of the class III antiarrhythmic agent azimilide in rodent models of ventricular arrhythmia.
    Brooks RR; Carpenter JF; Miller KE; Maynard AE
    Proc Soc Exp Biol Med; 1996 May; 212(1):84-93. PubMed ID: 8618956
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical differences between the newer antiarrhythmic agents.
    Camm AJ
    Europace; 2000 Jul; 1 Suppl C():C16-22. PubMed ID: 11220520
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Azimilide dihydrochloride.
    Carlson M
    Expert Rev Cardiovasc Ther; 2005 May; 3(3):387-91. PubMed ID: 15889966
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Drug therapy of ventricular arrhythmias - a contemporary perspective].
    Grönefeld GC; Hohnloser SH
    Dtsch Med Wochenschr; 2002 Oct; 127(43):2280-4. PubMed ID: 12397544
    [No Abstract]   [Full Text] [Related]  

  • 15. Effects of azimilide and d,l-sotalol on the heart rate and blood pressure response to isoproterenol in anesthetized rats.
    Mittelstadt SW; Maynard AE; Benn DR; Lowe ER; Kostreva DR
    Cardiovasc Drugs Ther; 1997 Sep; 11(4):591-8. PubMed ID: 9358964
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of isoproterenol on the class III effect of azimilide in humans.
    Dorian P; Dunnmon P; Elstun L; Newman D
    J Cardiovasc Pharmacol Ther; 2002 Oct; 7(4):211-7. PubMed ID: 12490966
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Azimilide: another effort to prevent implantable cardioverter-defibrillator shocks and their sequelae why it is important and how it works.
    Cannom DS; Gidney B
    J Am Coll Cardiol; 2008 Sep; 52(13):1084-5. PubMed ID: 18848142
    [No Abstract]   [Full Text] [Related]  

  • 18. Pure class III agents for prevention of sudden cardiac death.
    Pratt CM
    J Cardiovasc Electrophysiol; 2003 Sep; 14(9 Suppl):S82-6. PubMed ID: 12950526
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Azimilide for atrial fibrillation: clinical trial results and implications.
    Pritchett EL; Marcello SR
    Card Electrophysiol Rev; 2003 Sep; 7(3):215-9. PubMed ID: 14739716
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The class III effect of azimilide is not associated with reverse use-dependence in open-chest dogs.
    Qi XQ; Newman D; Dorian P
    J Cardiovasc Pharmacol; 1999 Dec; 34(6):898-903. PubMed ID: 10598136
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.